Now, FSSAI in soup as 11 food, pharma organisations seek CBI inquiry against the regulator

As many as 11 industry bodies related to food and pharma sectors Thursday alleged that the food regulator FSSAI has become "den of corruption" and demanded a CBI inquiry into the functioning of the authority, which shot to limelight over the Maggi issue.

Govt assures all help to boost pharma exports

Government Tuesday assured the pharma industry of "every possible help" in resolving its issues related to exports and said efforts would be made to expedite work on different proposals to realise the full potential of the sector.

PSUs in pharma sector will not be sold: Ananth Kumar

Public sector undertakings in pharmaceuticals sector will not be sold but their assets will be leveraged to make them financially viable, the government said today.

Cipla elevates Samina Vaziralli to its board

Drug major Cipla Thursday announced the appointment of Samina Vaziralli as executive director on its board, paving way for a bigger role for her, nearly two weeks after another heir apparent Kamil Hamied quiting the pharma company.

Govt approves FDI worth Rs 4,000 cr in pharma sector
Govt approves FDI worth Rs 4,000 cr in pharma sector

Proposals for foreign direct investment amounting to around Rs 4,000 crore by four pharma and medical devices firms, including Torrent Pharmaceuticals and Biocon's research services arm Syngene, were on Wednesday approved by the government.

NPPA gives deadline to drug cos for online data registration

Drug price regulator NPPA has given pharma firms time till Friday to register for online database with 19 out of top 100 drug makers yet to respond after repeated reminders.

'Pharma industry grappling with pricing, regulatory issues'

The buoyant pharmaceutical industry is still struggling to deal with the challenges around pricing in the domestic market, increased regulations as well as data integrity, says an EY survey.

Glenmark issues over 1 cr shares to Aranda, raises Rs 945 cr

Glenmark Pharmaceuticals has raised Rs 945 crore by issuing over 1 crore shares to Aranda Investments, an indirect subsidiary of Temasek Holdings.

Dr Reddy's Lab to enter Japanese market through a partner

Pharmaceutical major Dr Reddy's Laboratories Tuesday said it has plans to enter Japanese market through partnerships for specific products.

'Pharma exports may have grown 2.2% to $15.2 bn in FY15'

Indian pharma exports are estimated to have grown, but at a slower pace of 2.2 percent to about USD 15.2 billion during the financial year ended March 2015 against USD 14.9 billion in the previous fiscal, said a top official of Pharmexcil, an export promotion body, Monday.

Shanghvi did not buy Daiichi Sankyo's shares: Sun Pharma

The company was clarifying on speculations that Sanghvi, who holds 9.61 percent stake in Sun Pharma, had bought shares when Daiichi Sankyo exited from the Indian firm.

Daiichi Sankyo to offload stake in Sun Pharma worth Rs 22,000 cr

Japanese drug maker Daiichi Sankyo Monday said it board has approved selling a part or entire 9 percent holding worth over Rs 22,000 crore in Indian drug major Sun Pharmaceutical.

Pharma shares fall; Sun Pharma top loser on Sensex

Pharma shares fell by up to 3.6 percent Thursday amid reports that global brokerage firm Bank of America Merrill Lynch has downgraded some of the drug firms.

Govt allows pharma companies to hike prices of 509 essential drugs

The government has allowed pharmaceutical companies to hike rates of 509 essential medicines used for treating various ailments like diabetes, hepatitis and cancer by 3.84 percent with effect from April 1.

Govt may set up new Ministry for pharmaceuticals sector

The government may establish a separate Ministry for the pharmaceuticals sector, which would comprise all departments that deal with issues related to the industry.

FIPB refers Rs 4,197 cr Glenmark, Aurobindo proposals to CCEA

The Finance Ministry Thursday referred the foreign investment proposals worth Rs 4,187 crore in pharma firms - Glenmark and Aurobindo - to the Cabinet Committee on Economic Affairs.

R&D activities in pharma may get tax boost in Budget

"There is an urgent need to boost R&D in the pharma sector. India is the hub of generic medicines. It contributes significantly to the country's total exports," the official added.

FDI medical devices policy to come into effect from Jan 21

Cabinet last month approved liberalising FDI policy for medical devices sector.

Govt approves 100% FDI in medical devices sector

Government allowed 100 percent FDI under automatic route in medical devices sector to encourage manufacturing of equipments, including diagnostic kits and other devices.

Cabinet approves 100% FDI for medical devices sector

Medical devices include wide range of products such as sutures, implants and surgical instruments.